Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1

Conditions

Thyroid Neoplasms 7Thyroid Cancer, Papillary 3Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Renal Cell 3Breast Neoplasms 3Adenocarcinoma, Follicular 3Salivary Gland Neoplasms 2Recurrence 2Ovarian Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Endometrial Neoplasms 2Carcinoma, Medullary 2Carcinoma, Hepatocellular 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Nervous System Neoplasms 1Nasopharyngeal Carcinoma 1Multiple Myeloma 1Melanoma 1Lymphoma 1

Interventions

Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nervous System Neoplasms × Sunitinib × Head & Neck × Clear all
NCT00437372 2025-05-02

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Thomas Jefferson University

Phase 1 Completed
39 enrolled
GynecologicHead & NeckThoracic

Head and Neck Neoplasms, Neoplasms, Nervous System Neoplasms, Pelvic Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡